Probiotic Lactobacillus plantarum P8 alleviated stress and anxiety while enhancing memory and cognition in stressed adults: A randomised, double-blind, placebo-controlled study

2019 ◽  
Vol 38 (5) ◽  
pp. 2053-2064 ◽  
Author(s):  
Lee-Ching Lew ◽  
Yan-Yan Hor ◽  
Nur Asmaa’ A. Yusoff ◽  
Sy-Bing Choi ◽  
Muhamad S.B. Yusoff ◽  
...  
Keyword(s):  
Lactobacillus Plantarum ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Probiotic Lactobacillus

Clinical Evidence of Effects of Lactobacillus plantarum HY7714 on Skin Aging: A Randomized, Double Blind, Placebo-Controlled Study

2015 ◽  
Vol 25 (12) ◽  
pp. 2160-2168 ◽  
Author(s):  
Dong Eun Lee ◽  
Chul-Sung Huh ◽  
Jehyeon Ra ◽  
Il-Dong Choi ◽  
Ji-Woong Jeong ◽  
...  
Keyword(s):  
Lactobacillus Plantarum ◽  
Clinical Evidence ◽  
Skin Aging ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals Effects of Lactobacillus plantarum PS128 on Children with Autism Spectrum Disorder in Taiwan: A Randomized, Double-Blind, Placebo-Controlled Trial

Nutrients ◽  
2019 ◽  
Vol 11 (4) ◽  
pp. 820 ◽  
Author(s):  
Liu ◽  
Liong ◽  
Chung ◽  
Huang ◽  
Peng ◽  
...  
Keyword(s):  
Autism Spectrum Disorder ◽  
Lactobacillus Plantarum ◽  
Outcome Measure ◽  
Autism Spectrum ◽  
Spectrum Disorder ◽  
Secondary Outcome ◽  
Controlled Study ◽  
Secondary Outcome Measure ◽  
Double Blind ◽  
Double Blind Placebo

This four-week, randomized, double-blind, placebo-controlled study investigated the effects of Lactobacillus plantarum PS128 (PS128) on boys with autism spectrum disorder (ASD) aged 7–15 in Taiwan. All subjects fulfilled the criteria for ASD diagnosis of DSM-V and the Autism Diagnostic Interview-Revised (ADI-R). Questionnaires used for the primary outcome measure include the Autism Behavior Checklist-Taiwan version (ABC-T), the Social Responsiveness Scale (SRS) and the Child Behavior Checklist (CBCL). The Swanson, Nolan, and Pelham-IV-Taiwan version (SNAP-IV) and the Clinical Global Impression-improvement (CGI-I) were used for the secondary outcome measure. The results showed that PS128 ameliorated opposition/defiance behaviors, and that the total score of SNAP-IV for younger children (aged 712) improved significantly compared with the placebo group. Additionally, several elements were also notably improved in the PS128 group after 28-day consumption of PS128. Further studies are needed to better clarify the effects of PS128 for younger children with ASD on broader symptoms.

884: Phase I, Double-Blind, Placebo-Controlled Study in Healthy Male Subjects to Investigate the Safety, Tolerability, and Pharmacokinetics of DA-8159

2004 ◽  
Vol 171 (4S) ◽  
pp. 234-234 ◽  
Author(s):  
Harin Padma-Nathan ◽  
Jae Seung Pacik ◽  
Byoung Ok Ahn ◽  
Kyung Koo Kang ◽  
Mi Young Bahng ◽  
...  
Keyword(s):  
Phase I ◽  
Controlled Study ◽  
Healthy Male ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Male Subjects
Sign in / Sign up

Export Citation Format

Share Document